FOXO4-DRI (Proxofim)
⚠️ Disclaimer: For Research Use Only. Not for human administration or clinical therapy.
Basic Information
- CAS No.: 2460055-10-9
- Alias: FOXO4, FOXO4 D-Retro-Inverso peptide, Proxofim
- Sequence (1-letter D-amino acid): H-D-Leu-D-Thr-D-Leu-D-Arg-D-Lys-D-Glu-D-Pro-D-Ala-D-Ser-D-Glu-D-Ile-D-Ala-D-Gln-D-Ser-D-Ile-D-Leu-D-Glu-D-Ala-D-Tyr-D-Ser-D-Gln-D-Asn-D-Gly-D-Trp-D-Ala-D-Asn-D-Arg-D-Arg-D-Ser-D-Gly-D-Gly-D-Lys-D-Arg-D-Pro-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-D-Gly-OH
- Molecular Formula: \(\boldsymbol{C_{228}H_{388}N_{86}O_{64}}\)
- Molecular Weight: 5358.05 g/mol
- Appearance: White to off-white lyophilized powder
- Solubility: Soluble in bacteriostatic water / sterile water
- Storage: Lyophilized powder stored at -20℃, protected from light and moisture. Avoid repeated freeze-thaw cycles. After reconstitution, refrigerate and use promptly.
Development Background
FOXO4-DRI (Proxofim) is a synthetic D-retro-inverso peptide developed by researchers at Erasmus University Medical Center Rotterdam, first published in Cell (2017). It is rationally designed based on the FOXO4 forkhead domain protein sequence. The retro-inverso design uses reversed sequence + D-amino acids, which mimics the 3D binding surface of native FOXO4 while making the peptide highly resistant to protease degradation. It also carries a cell-penetrating TAT domain for intracellular delivery.
Mechanism of Action (Research Findings)
- Competes with endogenous FOXO4 protein to disrupt the FOXO4–p53 protein-protein interaction inside senescent cells.
- In senescent cells, FOXO4 binds p53 and traps p53 inside the nucleus, preventing apoptosis and allowing damaged “zombie cells” to survive.
- FOXO4-DRI breaks this complex, releasing p53 to translocate to mitochondria and trigger selective apoptosis in senescent cells.
- Healthy normal cells are largely spared.
- Reduces SASP (senescence-associated secretory phenotype), lowering chronic inflammation driven by senescent cells.
Research Areas
- Senolytic research, selective clearance of senescent cells
- Aging, frailty and age-related tissue degeneration animal models
- Chronic inflammation & SASP signaling
- Renal aging, cartilage degeneration, reproductive tissue aging
- FOXO transcription factor and p53 protein-protein interaction study
- Preclinical research for age-associated diseases








评价
目前还没有评价